Pemetrexed dipotassium is a chemotherapy drug used mainly to treat certain cancers including non-small cell lung cancer and malignant pleural mesothelioma. It is a folate analog metabolic inhibitor that disrupts folate-dependent processes essential for cancer cell replication by inhibiting enzymes like thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase, thereby impeding DNA and RNA synthesis in cancer cells. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pemetrexed dipotassium salt. Its PubChem CID is 136266586.
Pemetrexed dipotassium
| CAS No | 1438895-00-1 |
|---|---|
| Molecular Formula | C20H19K2N5O6 |
| Molecular Weight | 503.6 g/mol |
| Synonyms | dipotassium;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pemetrexed dipotassium is a chemotherapy drug used mainly to treat certain cancers including non-small cell lung cancer and malignant pleural mesothelioma.
The listed CAS number is 1438895-00-1.
The listed molecular formula is C20H19K2N5O6.
The listed molecular weight is 503.6 g/mol.
dipotassium;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate.
The source lists Pemetrexed dipotassium salt.